Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

All patients with small intramural rectal cancers are at risk for lymph node metastasis


PURPOSE: Although local excision can be curative in patients with early-stage rectal cancer, approximately 20 percent of patients will develop local recurrence, many as a result of unrecognized and unresected regional lymph node metastases. Our objective was to determine if standard pathologic factors can predict lymph node metastases in small intramural rectal cancers and provide a basis for patient selection for nonradical surgery. METHODS: Between June 1986 and September 1996, 318 patients with T1 or T2 rectal cancers underwent radical resection at our institution. Of these, 159 patients (48 T1 and 111 T2) were potentially eligible for curative local excision (≤4 cm in size, ≤10 cm from the anal verge, no synchronous metastases), and the prevalence of lymph node metastases based on T stage and other pathologic factors was analyzed in this group. RESULTS: The overall frequency of lymph node metastasis was 15 percent (24/159 patients). T stage (T1, 10 percent; T2, 17 percent), differentiation (well-differentiated or moderately differentiated, 14 percent and poorly differentiated, 30 percent), and lymphatic vessel invasion (lymphatic vessel invasion-negative, 14 percent and lymphatic vessel invasion-positive, 33 percent) influenced the risk of lymph node metastasis. However, only blood vessel invasion (blood vessel invasion-negative, 13 percent and blood vessel invasion-positive, 33 percent) reached statistical significance as a single predictive factor (P=0.04). Tumors with no adverse pathologic features (low-risk group) had a lower overall frequency of lymph node metastasis (11 percent) compared with the remaining tumors (high-risk group, 31 percent;P=0.008). However, even in the most favorable group (T1 cancers with no adverse pathologic features) lymph node metastases were present in 7 percent of patients. CONCLUSION: In rectal cancer patients potentially eligible for local excision, the overall risk of undetected and untreated lymph node metastases is considerable (15 percent). The use of pathologic factors alone after local excision does not reliably assure the absence of lymph node metastases.

This is a preview of subscription content, log in to check access.


  1. 1.

    Whiteway J, Nicholls RJ, Morson BC. The role of surgical local excision in the treatment of rectal cancer. Br J Surg 1985;72:694–7.

  2. 2.

    Stearns MW, Sternberg SS, DeCosse JJ. Treatment alternatives: localized rectal cancer. Cancer 1984;54:2691–4.

  3. 3.

    Biggers OR, Beart RW Jr, Ilstrup DM. Local excision of rectal cancer. Dis Colon Rectum 1986;29:374–7.

  4. 4.

    Graham RA, Garnsey L, Jessup JM. Local excision of rectal carcinoma. Am J Surg 1990;160:306–12.

  5. 5.

    Steele GD, Herndon JE, Burgess AM,et al. Cancer, and Leukemia Group B (CALGB), Radiation Therapy Oncology Group (RTOG), Eastern Cooperative Oncology Group (ECOG), Southwest Oncology Group (SWOG). Sphincter sparing treatment for distal rectal adenocarcinoma: a phase II intergroup study. Proc ASCO 1997;16:256a.

  6. 6.

    Steele GD, Jessup JM. Colorectal cancer. In: Steele GD, Jessup JM, Winchester DP, Menck HR, Murphy GP, eds. National Cancer Database. Annual Review of Patient Care 1995. Atlanta: American Cancer Society, 1995.

  7. 7.

    Blumberg D, Paty PB, Picon AI,et al. Stage I Rectal Cancer. Identification of High Risk Patients. J Am Coll Surg 1998;186:574–80.

  8. 8.

    Wolmark N, Fisher B, Wieand HS. The prognostic value of the modifications of the Dukes' C class of colorectal cancer. Ann Surg 1986;203:115–22.

  9. 9.

    Huddy SP, Husband EM, Cook MG, Gibbs NM, Marks CG, Heald RJ. Lymph node metastases in early rectal cancer. Br J Surg 1993;80:1457–8.

  10. 10.

    Cohen AM, Wood WC, Gunderson LL, Shinnar M. Pathological studies in rectal cancer. Cancer 1980;45:2965–8.

  11. 11.

    Minsky BD, Rich T, Recht A, Harvey W, Mies C. Selection criteria for local excision with or without adjuvant radiation therapy for rectal cancer. Cancer 1989;63:1421–9.

  12. 12.

    Zenni GC, Abraham K, Harford FJ, Potocki DM, Herman C, Dobrin PB. Characteristics of rectal carcinomas that predict the presence of lymph node metastases: implications for patient selection for local therapy. J Surg Oncol 1998;67:99–103.

  13. 13.

    Saclarides TJ, Bhattacharyya AK, Britton-Kuzel C, Szeluga D, Economou SG. Predicting lymph node metastases in rectal cancer. Dis Colon Rectum 1994;37:52–7.

  14. 14.

    Brodsky JT, Richard GK, Cohen AM, Minsky BD. Variables correlated with the risk of lymph node metastasis in early rectal cancer. Cancer 1992;69:322–6.

Download references

Author information

Correspondence to Dr. Philip B. Paty M.D..

About this article

Cite this article

Blumberg, D., Paty, P.B., Guillem, J.G. et al. All patients with small intramural rectal cancers are at risk for lymph node metastasis. Dis Colon Rectum 42, 881–885 (1999).

Download citation

Key words

  • Rectal cancer
  • Metastasis
  • Lymph nodes
  • Local excision